Stock Updates

Is this Large Market Cap Stock target price reasonable for Charles River Laboratories International, Inc. (NYSE:CRL)?

The company in question is, Charles River Laboratories International, Inc. (NYSE:CRL) currently with a stock price of 80.7 (-0.26% today). The market cap for Charles River Laboratories International, Inc. is 3838.37, and is in the sector Healthcare, and Medical Laboratories & Research industry. The target price for Charles River Laboratories International, Inc. is 89.54. Currently Charles River Laboratories International, Inc. is trading with a P/E of 27.03, and a forward P/E of 15.96. Average volume for Charles River Laboratories International, Inc. is 332.21 and so far today it is 94595.

Performance in the last year for Charles River Laboratories International, Inc. has been 26.64%. For EPS growth, Charles River Laboratories International, Inc. has seen a growth of 16.80%, and is looking to grow in the next year to 13.73%. More long term stats show that EPS growth has been 21.10% over the last five years and could be 12.52% for the next five years. Charles River Laboratories International, Inc. has seen sales growth quarter over quarter at 27.80%, with EPS growth quarter over quarter at -28.00%. The 20-day simple moving average is -2.37%, with the 200-day simple moving average coming to 0.53%.

Since the IPO date for Charles River Laboratories International, Inc. on the 6/23/2000, Charles River Laboratories International, Inc. has seen performance year to date to be 0.65%. With Charles River Laboratories International, Inc. trading at 80.7, the dividend yield is *TBA, and the EPS is 2.99.

So could Charles River Laboratories International, Inc., be undervalued? Well as said before P/E is 27.03. The PEG is 2.16, P/S is 2.57 and the P/B is at 4.58. The P/cash is 21.37, with P/free cash flow at 15.56.

Charles River Laboratories International, Inc. ability to deal with debt shows that the current ratio is 1.7, and the quick ratio is 1.5. This is with long term debt/equity at 1.6, and total debt/equity at 1.64.

In terms of margins, Charles River Laboratories International, Inc. has a gross margin of 39.50%, an operating margin of 14.60% and a profit margin of 9.50%.Payout ratio for Charles River Laboratories International, Inc. is 0.00%. Return on assets come to 6.30% with return on investment coming to 10.20%.

Insider ownership for Charles River Laboratories International, Inc., is at 1.10% and institutional ownership comes to *TBA. Outstanding shares are at 47.44. While shares float is 46.53. The float short is currently 3.45%, and short ratio is 4.83.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment